Exact Mass: 443.3147756000001

Exact Mass Matches: 443.3147756000001

Found 456 metabolites which its exact mass value is equals to given mass value 443.3147756000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dynorphin A (6-8)

(2R,3R)-2-{[(2S)-2-{[(2R)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-5-carbamimidamido-1-hydroxypentylidene]amino}-3-methylpentanoate

C18H37N9O4 (443.29683620000003)


Dynorphin A (6-8) is a fraction of Dynorphin A with only Arg-Arg-Ile peptide chain. Dynorphin A is an endogenous opioid peptide that produces non-opioid receptor-mediated neural excitation.Dynorphin induces calcium influx via voltage-sensitive calcium channels in sensory neurons by activating bradykinin receptors. This action of dynorphin at bradykinin receptors is distinct from the primary signaling pathway activated by bradykinin and underlies the hyperalgesia produced by pharmacological administration of dynorphin by the spinal route in rats and mice. Blockade of spinal B1 or B2 receptor also reverses persistent neuropathic pain but only when there is sustained elevation of endogenous spinal dynorphin, which is required for maintenance of neuropathic pain. These data reveal a mechanism for endogenous dynorphin to promote pain through its agonist action at bradykinin receptors and suggest new avenues for therapeutic intervention. Dynorphin A is a form of dynorphin.Dynorphins are a class of opioid peptides that arise from the precursor protein prodynorphin. When prodynorphin is cleaved during processing by proprotein convertase 2 (PC2), multiple active peptides are released: dynorphin A, dynorphin B, and a/b-neo-endorphin. Depolarization of a neuron containing prodynorphin stimulates PC2 processing, which occurs within synaptic vesicles in the presynaptic terminal. Occasionally, prodynorphin is not fully processed, leading to the release of "big dynorphin."This 32-amino acid molecule consists of both dynorphin A and dynorphin B.Dynorphin A, dynorphin B, and big dynorphin all contain a high proportion of basic amino acid residues, in particular lysine and arginine (29.4\\%, 23.1\\%, and 31.2\\% basic residues, respectively), as well as many hydrophobic residues (41.2\\%, 30.8\\%, and 34.4\\% hydrophobic residues, respectively). Although dynorphins are found widely distributed in the CNS, they have the highest concentrations in the hypothalamus, medulla, pons, midbrain, and spinal cord. Dynorphins are stored in large (80-120 nm diameter) dense-core vesicles that are considerably larger than vesicles storing neurotransmitters. These large dense-core vesicles differ from small synaptic vesicles in that a more intense and prolonged stimulus is needed to cause the large vesicles to release their contents into the synaptic cleft. Dense-core vesicle storage is characteristic of opioid peptides storage. The first clues to the functionality of dynorphins came from Goldstein et al. in their work with opioid peptides. The group discovered an endogenous opioid peptide in the porcine pituitary that proved difficult to isolate. By sequencing the first 13 amino acids of the peptide, they created a synthetic version of the peptide with a similar potency to the natural peptide. Goldstein et al. applied the synthetic peptide to the guinea ileum longitudinal muscle and found it to be an extraordinarily potent opioid peptide. The peptide was called dynorphin (from the Greek dynamis=power) to describe its potency. Dynorphins exert their effects primarily through the κ-opioid receptor (KOR), a G-protein-coupled receptor. Two subtypes of KORs have been identified: K1 and K2. Although KOR is the primary receptor for all dynorphins, the peptides do have some affinity for the μ-opioid receptor (MOR), d-opioid receptor (DOR), N-methyl-D-aspartic acid (NMDA)-type glutamate receptor. Different dynorphins show different receptor selectivities and potencies at receptors. Big dynorphin and dynorphin A have the same selectivity for human KOR, but dynorphin A is more selective for KOR over MOR and DOR than is big dynorphin. Big dynorphin is more potent at KORs than is dynorphin A. Both big dynorphin and dynorphin A are more potent and more selective than dynorphin B (Wikipedia). Dynorphin A (6-8) is a fraction of Dynorphin A with only Arg-Arg-Ile peptide chain

   

12-Hydroxy-12-octadecanoylcarnitine

3-[(12-hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C25H49NO5 (443.36105440000006)


12-Hydroxy-12-octadecanoylcarnitine is an acylcarnitine. More specifically, it is an 12-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 12-Hydroxy-12-octadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 12-hydroxy-12-octadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 12-hydroxy-12-octadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane.  Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

3-Hydroxyoctadecanoylcarnitine

3-[(3-Hydroxyoctadecanoyl)oxy]-4-(trimethylammonio)butanoic acid

C25H49NO5 (443.36105440000006)


3-Hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 3-Hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 3-Hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Hydroxyoctadecanoylcarnitine

3-[(10-Hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C25H49NO5 (443.36105440000006)


10-Hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 10-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 10-Hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 10-Hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 10-Hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Hydroxyoctadecanoylcarnitine

3-[(9-hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C25H49NO5 (443.36105440000006)


9-hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 9-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 9-hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 9-hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

13-Hydroxyoctadecanoylcarnitine

3-[(13-hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C25H49NO5 (443.36105440000006)


13-hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 13-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 13-hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 13-hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 13-hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxyoctadecanoylcarnitine

3-[(5-Hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C25H49NO5 (443.36105440000006)


5-hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 5-hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 5-hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyoctadecanoylcarnitine

3-[(7-Hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C25H49NO5 (443.36105440000006)


7-hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 7-hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 7-hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Hydroxyoctadecanoylcarnitine

3-[(8-Hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C25H49NO5 (443.36105440000006)


8-hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 8-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 8-hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 8-hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

11-Hydroxyoctadecanoylcarnitine

3-[(11-hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C25H49NO5 (443.36105440000006)


11-hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 11-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 11-hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 11-hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 11-hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyoctadecanoylcarnitine

3-[(6-hydroxyoctadecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C25H49NO5 (443.36105440000006)


6-hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine 6-hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular 6-hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with coronary artery disease (PMID: 20173117). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2S)-2-Hydroxyoctadecanoylcarnitine

(2S)-2-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


(2S)-2-hydroxyoctadecanoylcarnitine is an acylcarnitine. More specifically, it is an (2S)-2-hydroxyoctadecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S)-2-hydroxyoctadecanoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (2S)-2-hydroxyoctadecanoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. In particular (2S)-2-hydroxyoctadecanoylcarnitine is elevated in the blood or plasma of individuals with carnitine-acylcarnitine translocase deficiency (PMID: 12403251), chronic fatigue syndrome (PMID: 21205027), pulmonary Arterial Hypertension (PMID: 27006481), carnitine palmitoyl Transferase 2 Deficiency (PMID: 15653102), cardiovascular mortality in chronic kidney disease (PMID: 24308938), diastolic heart failure (PMID: 27473038), and systolic heart failure (PMID: 27473038). It is also decreased in the blood or plasma of individuals with intracerebral hemorrhage (PMID: 29265114), and carnitine palmitoyl transferase 1A deficiency (PMID: 11568084). Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Linoleoyl Tyrosine

(2S)-3-(4-Hydroxyphenyl)-2-(octadeca-9,12-dienoylamino)propanoate

C27H41NO4 (443.30354260000007)


N-linoleoyl tyrosine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Tyrosine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Tyrosine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Tyrosine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Docosahexaenoyl Aspartic acid

2-[(1-Hydroxydocosa-4,7,10,13,16,19-hexaen-1-ylidene)amino]butanedioate

C26H37NO5 (443.26715920000004)


N-docosahexaenoyl aspartic acid belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Aspartic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Aspartic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Aspartic acid is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate

5-hydroxy-2,6,15-trimethyl-14-(6-methylheptan-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-ene-6-carboxylate

C29H47O3 (443.3525012)


3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate can be found in a number of food items such as cornmint, black elderberry, garden rhubarb, and black radish, which makes 3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate a potential biomarker for the consumption of these food products.

   

(+)-N-Deoxymilitarinone A

(+)-N-Deoxymilitarinone A

C26H37NO5 (443.26715920000004)


   

Piericidin B5

Piericidin B5

C27H41NO4 (443.30354260000007)


   

Spiramine E

Spiramine E

C26H37NO5 (443.26715920000004)


   

Yibeissine

Yibeissine

C27H41NO4 (443.30354260000007)


   

Puqienine B

Puqienine B

C28H45NO3 (443.339926)


   

12-Acetyllucidusculine

12-Acetyllucidusculine

C26H37NO5 (443.26715920000004)


   

1-Hydroxy-5,6-dihydrojervine

1-Hydroxy-5,6-dihydrojervine

C27H41NO4 (443.30354260000007)


   

Spiramine Z

Spiramine Z

C26H37NO5 (443.26715920000004)


   

Veratrenon|Veratrenone

Veratrenon|Veratrenone

C27H41NO4 (443.30354260000007)


   

Piericidin B2

Piericidin B2

C27H41NO4 (443.30354260000007)


   

C28H45NO3

C28H45NO3 (443.339926)


   

Piericidin A3

Piericidin A3

C27H41NO4 (443.30354260000007)


   

torrubiellutin A

torrubiellutin A

C26H37NO5 (443.26715920000004)


   

stachybotrin A

stachybotrin A

C26H37NO5 (443.26715920000004)


   

clionamine A

clionamine A

C28H45NO3 (443.339926)


   

(23R)-17,23-epoxy-3beta,14-dihydroxy-(5alpha)-veratr-13(18)-en-6-one|Edpetin|edpetine

(23R)-17,23-epoxy-3beta,14-dihydroxy-(5alpha)-veratr-13(18)-en-6-one|Edpetin|edpetine

C27H41NO4 (443.30354260000007)


   

Arg-Arg-Leu|RRL

Arg-Arg-Leu|RRL

C18H37N9O4 (443.29683620000003)


   

Nakijiquinone B

Nakijiquinone B

C26H37NO5 (443.26715920000004)


   

C24H45NO6

C24H45NO6 (443.324671)


   

2-(14-Hydroxy-14,15-dimethylhexadecyl)-3-methoxyquinoline-4(1H)-one

2-(14-Hydroxy-14,15-dimethylhexadecyl)-3-methoxyquinoline-4(1H)-one

C28H45NO3 (443.339926)


   

arginylisoleucylarginine

arginylisoleucylarginine

C18H37N9O4 (443.29683620000003)


   

Yibeissine

(3S,3R,3aS,4aS,6S,6aS,6bS,7aR,9R,11R,11aS,11bR)-3,11-dihydroxy-3,6,10,11b-tetramethylspiro[1,2,3,4,4a,6,6a,6b,7,8,11,11a-dodecahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-5-one

C27H41NO4 (443.30354260000007)


Yibeissine is a steroidal alkaloid isolated from the bulb of Fritillaria pallioiflora Schren[1]. Yibeissine is a steroidal alkaloid isolated from the bulb of Fritillaria pallioiflora Schren[1].

   

C27H41NO4_(7E)-3-Isobutyl-4,5,8,12,12-pentamethyl-3,3a,4,6a,9,10,10a,13a,14,15-decahydro-1H-[1,3]dioxolo[7,8]cycloundeca[1,2-d]isoindole-1,16(2H)-dione

NCGC00380117-01_C27H41NO4_(7E)-3-Isobutyl-4,5,8,12,12-pentamethyl-3,3a,4,6a,9,10,10a,13a,14,15-decahydro-1H-[1,3]dioxolo[7,8]cycloundeca[1,2-d]isoindole-1,16(2H)-dione

C27H41NO4 (443.30354260000007)


   

Inaequalisine_A

Inaequalisine_A

[C29H35N2O2]+ (443.269839)


   

Ala Ile Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Ile Ile Gln

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ala Ile Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Ile Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Ile Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Ile Leu Gln

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ala Ile Gln Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ala Ile Gln Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ala Lys Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Lys Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Lys Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Lys Leu Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Leu Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Leu Ile Gln

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ala Leu Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Leu Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Leu Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Ala Leu Leu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ala Leu Gln Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ala Leu Gln Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ala Gln Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-methylpentanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ala Gln Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-methylpentanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ala Gln Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-4-methylpentanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ala Gln Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-4-methylpentanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ala Arg Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Ala Val Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Ala Val Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Gly Ile Arg Val

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Gly Ile Val Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Gly Leu Arg Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Gly Leu Val Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Gly Arg Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Gly Arg Leu Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Gly Arg Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Gly Arg Val Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Gly Val Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Gly Val Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Gly Val Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Gly Val Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Ile Ala Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Ala Ile Gln

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ile Ala Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Ala Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Ala Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Ala Leu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ile Ala Gln Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ile Ala Gln Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ile Arg Arg

Ile Arg Arg

C18H37N9O4 (443.29683620000003)


   

Arg Arg Ile

Arg Arg Ile

C18H37N9O4 (443.29683620000003)


   

Ile Gly Arg Val

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Arg Arg Leu

Arg Arg Leu

C18H37N9O4 (443.29683620000003)


   

Ile Gly Val Arg

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Ile Ile Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]propanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Ile Ala Gln

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]propanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ile Ile Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]hexanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Ile Gln Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-4-carbamoylbutanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Ile Lys Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]propanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Lys Ala Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]propanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Lys Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylpentanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Lys Leu Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-methylpentanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Lys Pro Ser

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Ile Lys Ser Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Ile Leu Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]propanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Leu Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]propanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ile Leu Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]hexanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Ile Leu Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-4-carbamoylbutanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Ile Asn Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ile Pro Lys Ser

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Ile Pro Ser Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Ile Gln Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]propanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ile Gln Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]propanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ile Gln Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]-3-methylpentanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Ile Gln Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-carbamoylbutanamido]-4-methylpentanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Ile Arg Gly Val

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]acetamido}-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Ile Arg Val Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Ile Ser Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Ile Ser Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O6 (443.2743702)


   

Ile Val Gly Arg

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]acetamido}-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Ile Val Asn Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Ile Val Arg Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Ile Val Val Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C20H37N5O6 (443.2743702)


   

Lys Ala Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Ala Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Ala Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Ala Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Ile Ala Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Ile Ala Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Arg Ile Arg

Arg Ile Arg

C18H37N9O4 (443.29683620000003)


   

Lys Ile Ile Ala

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylpentanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Ile Leu Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-4-methylpentanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Ile Pro Ser

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Lys Ile Ser Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Lys Leu Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Leu Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Leu Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylpentanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Leu Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-4-methylpentanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Lys Leu Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Lys Leu Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Lys Pro Ile Ser

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Lys Pro Leu Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Lys Pro Ser Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Lys Pro Ser Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Lys Pro Thr Val

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Lys Pro Val Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-hydroxybutanoic acid

C20H37N5O6 (443.2743702)


   

Lys Ser Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Lys Ser Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Lys Ser Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Lys Ser Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Lys Thr Pro Val

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Lys Thr Val Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Lys Val Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H37N5O6 (443.2743702)


   

Lys Val Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Lys Val Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Ala Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Ala Ile Gln

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-methylpentanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Leu Ala Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Ala Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Ala Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Ala Leu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-4-methylpentanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Leu Ala Gln Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-4-carbamoylbutanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Leu Ala Gln Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Leu Gly Arg Val

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Leu Gly Val Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Leu Ile Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]propanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Ile Ala Gln

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]propanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Leu Ile Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]hexanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Ile Gln Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-4-carbamoylbutanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Leu Lys Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]propanamido]-3-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Lys Ala Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]propanamido]-4-methylpentanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Lys Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylpentanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Lys Leu Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-methylpentanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Lys Pro Ser

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Leu Lys Ser Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Leu Leu Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]propanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Leu Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]propanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

Leu Leu Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]hexanamido]propanoic acid

C21H41N5O5 (443.31075360000006)


   

Leu Leu Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-4-carbamoylbutanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Leu Asn Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Leu Pro Lys Ser

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Leu Pro Ser Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Leu Gln Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]propanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Leu Gln Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]propanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Leu Gln Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]-3-methylpentanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Leu Gln Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]-4-methylpentanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Leu Arg Gly Val

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]acetamido}-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Leu Arg Val Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Leu Ser Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Leu Ser Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O6 (443.2743702)


   

Leu Val Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]acetamido}-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Leu Val Asn Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Leu Val Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Leu Val Val Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C20H37N5O6 (443.2743702)


   

Leu Arg Arg

Leu Arg Arg

C18H37N9O4 (443.29683620000003)


   

Asn Ile Val Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanamido]-3-methylbutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Asn Leu Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Asn Val Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-methylpentanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Asn Val Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Asn Val Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-methylbutanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Asn Val Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-methylbutanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Pro Ile Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]hexanamido]-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Pro Ile Ser Lys

(2S)-6-amino-2-[(2S)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Pro Lys Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Pro Lys Leu Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Pro Lys Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Pro Lys Ser Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Pro Lys Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Pro Lys Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C20H37N5O6 (443.2743702)


   

Pro Leu Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]hexanamido]-3-hydroxypropanoic acid

C20H37N5O6 (443.2743702)


   

Pro Leu Ser Lys

(2S)-6-amino-2-[(2S)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Pro Ser Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Pro Ser Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Pro Ser Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Pro Ser Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Pro Thr Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]hexanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Pro Thr Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Pro Val Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]hexanamido]-3-hydroxybutanoic acid

C20H37N5O6 (443.2743702)


   

Pro Val Thr Lys

(2S)-6-amino-2-[(2S,3R)-3-hydroxy-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Gln Ala Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Gln Ala Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Gln Ala Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Gln Ala Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Gln Ile Ala Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]propanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Gln Ile Ala Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]propanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Gln Ile Ile Ala

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]-3-methylpentanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Gln Ile Leu Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]-4-methylpentanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Gln Leu Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]propanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Gln Leu Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]propanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Gln Leu Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]-3-methylpentanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Gln Leu Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-methylpentanamido]-4-methylpentanamido]propanoic acid

C20H37N5O6 (443.2743702)


   

Gln Val Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]-3-methylbutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Arg Ala Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-methylbutanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Arg Gly Ile Val

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylpentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Arg Gly Leu Val

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-4-methylpentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Arg Gly Val Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylbutanamido]-3-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Arg Gly Val Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylbutanamido]-4-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Arg Ile Gly Val

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]acetamido}-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Arg Ile Val Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-methylbutanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Arg Leu Arg

Arg Leu Arg

C18H37N9O4 (443.29683620000003)


   

Arg Leu Gly Val

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]acetamido}-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Arg Leu Val Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-methylbutanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Arg Val Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]propanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Arg Val Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]acetamido}-3-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Arg Val Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]acetamido}-4-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Arg Val Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylpentanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Arg Val Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-4-methylpentanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Arg Val Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-methylbutanamido]propanoic acid

C19H37N7O5 (443.2856032)


   

Ser Ile Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Ser Ile Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O6 (443.2743702)


   

Ser Lys Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Ser Lys Leu Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Ser Lys Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ser Lys Pro Leu

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ser Leu Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Ser Leu Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O6 (443.2743702)


   

Ser Pro Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Ser Pro Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ser Pro Lys Leu

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Ser Pro Leu Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Thr Lys Pro Val

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Thr Lys Val Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Thr Pro Lys Val

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Thr Pro Val Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Thr Val Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Thr Val Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O6 (443.2743702)


   

Val Ala Arg Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Val Ala Val Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Val Gly Ile Arg

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Val Gly Leu Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Val Gly Arg Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Val Gly Arg Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Val Ile Gly Arg

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]acetamido}-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Val Ile Asn Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Val Ile Arg Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Val Ile Val Asn

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C20H37N5O6 (443.2743702)


   

Val Lys Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H37N5O6 (443.2743702)


   

Val Lys Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Val Lys Val Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H41N5O5 (443.31075360000006)


   

Val Leu Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]acetamido}-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Val Leu Asn Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Val Leu Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Val Leu Val Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C20H37N5O6 (443.2743702)


   

Val Asn Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Val Asn Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Val Asn Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Val Asn Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Val Pro Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-hydroxybutanoic acid

C20H37N5O6 (443.2743702)


   

Val Pro Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]hexanoic acid

C20H37N5O6 (443.2743702)


   

Val Gln Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanamido]-3-methylbutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Val Arg Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]propanamido]-3-methylbutanoic acid

C19H37N7O5 (443.2856032)


   

Val Arg Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]acetamido}-3-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Val Arg Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]acetamido}-4-methylpentanoic acid

C19H37N7O5 (443.2856032)


   

Val Arg Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Val Arg Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]acetic acid

C19H37N7O5 (443.2856032)


   

Val Arg Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]propanoic acid

C19H37N7O5 (443.2856032)


   

Val Thr Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C20H37N5O6 (443.2743702)


   

Val Thr Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C20H37N5O6 (443.2743702)


   

Val Val Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]propanamido]-5-carbamimidamidopentanoic acid

C19H37N7O5 (443.2856032)


   

Val Val Ile Asn

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-methylpentanamido]-3-carbamoylpropanoic acid

C20H37N5O6 (443.2743702)


   

Val Val Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]hexanamido]-3-methylbutanoic acid

C21H41N5O5 (443.31075360000006)


   

Val Val Leu Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-4-methylpentanamido]-3-carbamoylpropanoic acid

C20H37N5O6 (443.2743702)


   

Val Val Asn Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-3-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Val Val Asn Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-4-methylpentanoic acid

C20H37N5O6 (443.2743702)


   

Val Val Gln Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-4-carbamoylbutanamido]-3-methylbutanoic acid

C20H37N5O6 (443.2743702)


   

Val Val Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]propanoic acid

C19H37N7O5 (443.2856032)


   

Val Val Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-methylbutanamido]hexanoic acid

C21H41N5O5 (443.31075360000006)


   

Val Val Val Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-methylbutanamido]-4-carbamoylbutanoic acid

C20H37N5O6 (443.2743702)


   

cyclopropyl methyl amide

9α,11α,15R-trihydroxy-16-phenoxy-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-cyclopropyl methyl amide

C26H37NO5 (443.26715920000004)


   

diethyl amide

N-diethyl-9α,11α,15S-trihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-amide

C27H41NO4 (443.30354260000007)


   

CAR 18:0;O

3-[(3-hydroxyoctadecanoyl)oxy]-4-(trimethylammonio)butanoate;3-hydroxystearoylcarnitine

C25H49NO5 (443.36105440000006)


   

tris(2-hydroxyethyl)ammonium tetradecyl sulphate

tris(2-hydroxyethyl)ammonium tetradecyl sulphate

C20H45NO7S (443.29165800000004)


   

ammonium hydroxydinonylbenzenesulphonate

ammonium hydroxydinonylbenzenesulphonate

C24H45NO4S (443.30691300000007)


   

N-(cyclopropylmethyl)-7-[3,5-dihydroxy-2-(3-hydroxy-4-phenoxybut-1-enyl)cyclopentyl]hept-5-enamide

(5Z)-N-(Cyclopropylmethyl)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-phenoxy-1-buten-1-YL]cyclopentyl]-5-heptenamide

C26H37NO5 (443.26715920000004)


   

Arg-Arg-Leu

Arg-Arg-Leu

C18H37N9O4 (443.29683620000003)


   

3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate

5-hydroxy-2,6,15-trimethyl-14-(6-methylheptan-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-ene-6-carboxylate

C29H47O3 (443.3525012)


3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate can be found in a number of food items such as cornmint, black elderberry, garden rhubarb, and black radish, which makes 3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate a potential biomarker for the consumption of these food products. 3β-hydroxy-4β-methyl-5α-cholest-7-ene-4α-carboxylate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3β-hydroxy-4β-methyl-5α-cholest-7-ene-4α-carboxylate can be found in a number of food items such as cornmint, black elderberry, garden rhubarb, and black radish, which makes 3β-hydroxy-4β-methyl-5α-cholest-7-ene-4α-carboxylate a potential biomarker for the consumption of these food products.

   

2-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-methylbutanoic acid

2-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-methylbutanoic acid

C26H37NO5 (443.26715920000004)


   

3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate

3-Hydroxy-4,10,13-trimethyl-17-(6-methylheptan-2-yl)-1,2,3,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-4-carboxylate

C29H47O3- (443.3525012)


3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate can be found in a number of food items such as cornmint, black elderberry, garden rhubarb, and black radish, which makes 3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate a potential biomarker for the consumption of these food products.

   

3beta-Hydroxy-4beta-methyl-5alpha-cholest-8-ene-4alpha-carboxylate

3beta-Hydroxy-4beta-methyl-5alpha-cholest-8-ene-4alpha-carboxylate

C29H47O3- (443.3525012)


A steroid acid anion that is the conjugate base of 3beta-hydroxy-4beta-methyl-5alpha-cholest-8-ene-4alpha-carboxylic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

3beta-Hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate

3beta-Hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate

C29H47O3- (443.3525012)


   

4beta-Carboxy-4alpha-methyl-5alpha-cholesta-8-en-3beta-ol

4beta-Carboxy-4alpha-methyl-5alpha-cholesta-8-en-3beta-ol

C29H47O3- (443.3525012)


   

3beta-Hydroxy-4alpha-methyl-5alpha-cholest-7-ene-4beta-carboxylate

3beta-Hydroxy-4alpha-methyl-5alpha-cholest-7-ene-4beta-carboxylate

C29H47O3- (443.3525012)


   

3-(4-hydroxyphenyl)-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]propanoic acid

3-(4-hydroxyphenyl)-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]propanoic acid

C27H41NO4 (443.30354260000007)


   

9-Hydroxyoctadecanoylcarnitine

9-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

5-Hydroxyoctadecanoylcarnitine

5-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

7-Hydroxyoctadecanoylcarnitine

7-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

8-Hydroxyoctadecanoylcarnitine

8-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

6-Hydroxyoctadecanoylcarnitine

6-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

10-Hydroxyoctadecanoylcarnitine

10-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

13-Hydroxyoctadecanoylcarnitine

13-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

11-Hydroxyoctadecanoylcarnitine

11-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

(2S)-2-Hydroxyoctadecanoylcarnitine

(2S)-2-Hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

N-Docosahexaenoyl Aspartic acid

N-Docosahexaenoyl Aspartic acid

C26H37NO5 (443.26715920000004)


   

(12E)-7,7,12,16,17-pentamethyl-19-(2-methylpropyl)-6,8-dioxa-20-azatetracyclo[12.7.0.01,18.05,9]henicosa-12,15-diene-2,21-dione

(12E)-7,7,12,16,17-pentamethyl-19-(2-methylpropyl)-6,8-dioxa-20-azatetracyclo[12.7.0.01,18.05,9]henicosa-12,15-diene-2,21-dione

C27H41NO4 (443.30354260000007)


   

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

Arg-Leu-Arg

Arg-Leu-Arg

C18H37N9O4 (443.29683620000003)


   

Ile-Arg-Arg

Ile-Arg-Arg

C18H37N9O4 (443.29683620000003)


   

Arg-Ile-Arg

Arg-Ile-Arg

C18H37N9O4 (443.29683620000003)


   

Leu-Arg-Arg

Leu-Arg-Arg

C18H37N9O4 (443.29683620000003)


   

Arg-Arg-Ile

Arg-Arg-Ile

C18H37N9O4 (443.29683620000003)


   

4-[[[(2S,3R,5aS,10aS)-3-(4-hydroxyphenyl)-5,10-dioxo-1,2,3,5a,6,7,8,10a-octahydrodipyrrolo[1,2-c:1,3-f]pyrazin-2-yl]-oxomethyl]amino]butyl-trimethylammonium

4-[[[(2S,3R,5aS,10aS)-3-(4-hydroxyphenyl)-5,10-dioxo-1,2,3,5a,6,7,8,10a-octahydrodipyrrolo[1,2-c:1,3-f]pyrazin-2-yl]-oxomethyl]amino]butyl-trimethylammonium

C24H35N4O4+ (443.265817)


   

(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(4-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(2-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-9-[[methyl-[(3-methylphenyl)methyl]amino]methyl]-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C24H37N5O3 (443.28962520000005)


   

19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonadecanoate

19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonadecanoate

C25H47O6- (443.3372462)


   

(17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctadecanoate

(17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctadecanoate

C24H43O7- (443.3008628)


   

18-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctadecanoate

18-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctadecanoate

C24H43O7- (443.3008628)


   

(18R)-18-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxynonadecanoate

(18R)-18-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxynonadecanoate

C25H47O6- (443.3372462)


   

Ldgts 14:1

Ldgts 14:1

C24H45NO6 (443.324671)


   

(5Z,8Z,11Z,14Z,17Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]icosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]icosa-5,8,11,14,17-pentaenamide

C28H45NO3 (443.339926)


   

(4Z,7Z,10Z,13Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]hexadeca-4,7,10,13-tetraenamide

C28H45NO3 (443.339926)


   

(3Z,6Z,9Z,12Z,15Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]octadeca-3,6,9,12,15-pentaenamide

C28H45NO3 (443.339926)


   

Cer 9:0;3O/16:1;(2OH)

Cer 9:0;3O/16:1;(2OH)

C25H49NO5 (443.36105440000006)


   

Cer 12:0;3O/13:1;(2OH)

Cer 12:0;3O/13:1;(2OH)

C25H49NO5 (443.36105440000006)


   

Cer 12:1;3O/13:0;(2OH)

Cer 12:1;3O/13:0;(2OH)

C25H49NO5 (443.36105440000006)


   

Cer 10:0;3O/15:1;(2OH)

Cer 10:0;3O/15:1;(2OH)

C25H49NO5 (443.36105440000006)


   

Cer 11:0;3O/14:1;(2OH)

Cer 11:0;3O/14:1;(2OH)

C25H49NO5 (443.36105440000006)


   

Cer 13:0;3O/12:1;(2OH)

Cer 13:0;3O/12:1;(2OH)

C25H49NO5 (443.36105440000006)


   

Cer 13:1;3O/12:0;(2OH)

Cer 13:1;3O/12:0;(2OH)

C25H49NO5 (443.36105440000006)


   

Inaequalisine_A

Inaequalisine_A

C29H35N2O2+ (443.269839)


   

lysoDGTS 14:1

lysoDGTS 14:1

C24H45NO6 (443.324671)


   

12-Hydroxy-12-octadecanoylcarnitine

12-Hydroxy-12-octadecanoylcarnitine

C25H49NO5 (443.36105440000006)


   

3-hydroxyoctadecanoylcarnitine

3-hydroxyoctadecanoylcarnitine

C25H49NO5 (443.36105440000006)


An O-acylcarnitine having 3-hydroxyoctadecanoyl as the acyl substituent.

   

Dynorphin A (6-8)

Dynorphin A (6-8)

C18H37N9O4 (443.29683620000003)


   

ascr#34(1-)

ascr#34(1-)

C25H47O6 (443.3372462)


Conjugate base of ascr#34

   

oscr#34(1-)

oscr#34(1-)

C25H47O6 (443.3372462)


A monocarboxylic acid anion that is the conjugate base of oscr#34, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

CarE(18:0)

CarE(18:0(1+O))

C25H49NO5 (443.36105440000006)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Asp 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Asp 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C26H37NO5 (443.26715920000004)


   

NA-Cys 22:0

NA-Cys 22:0

C25H49NO3S (443.3432964000001)


   

NA-Dopamine 20:2(11Z,14Z)

NA-Dopamine 20:2(11Z,14Z)

C28H45NO3 (443.339926)


   

NA-His 20:3(8Z,11Z,14Z)

NA-His 20:3(8Z,11Z,14Z)

C26H41N3O3 (443.3147756000001)


   

NA-Ile 22:5(7Z,10Z,13Z,16Z,19Z)

NA-Ile 22:5(7Z,10Z,13Z,16Z,19Z)

C28H45NO3 (443.339926)


   

NA-Leu 22:5(7Z,10Z,13Z,16Z,19Z)

NA-Leu 22:5(7Z,10Z,13Z,16Z,19Z)

C28H45NO3 (443.339926)


   

NA-Met 20:0

NA-Met 20:0

C25H49NO3S (443.3432964000001)


   

NA-Phe 19:1(9Z)

NA-Phe 19:1(9Z)

C28H45NO3 (443.339926)


   

NA-Taurine 22:2(13Z,16Z)

NA-Taurine 22:2(13Z,16Z)

C24H45NO4S (443.30691300000007)


   

NA-Tyr 18:2(9E,12E)

NA-Tyr 18:2(9E,12E)

C27H41NO4 (443.30354260000007)


   

NA-Tyr 18:2(9Z,12Z)

NA-Tyr 18:2(9Z,12Z)

C27H41NO4 (443.30354260000007)


   

CAR 18:0;OH

CAR 18:0;OH

C25H49NO5 (443.36105440000006)


   

CAR 20:6

CAR 20:6

C27H41NO4 (443.30354260000007)


   

CAR DC17:0

CAR DC17:0

C24H45NO6 (443.324671)


   

MGCC 13:2

MGCC 13:2

C23H41NO7 (443.28828760000005)


   

MGTS 14:1

MGTS 14:1

C24H45NO6 (443.324671)


   

Cer 9:0;O3/16:1;O

Cer 9:0;O3/16:1;O

C25H49NO5 (443.36105440000006)


   

ST 24:4;O3;Gly

ST 24:4;O3;Gly

C26H37NO5 (443.26715920000004)


   

ST 25:3;O2;Gly

ST 25:3;O2;Gly

C27H41NO4 (443.30354260000007)


   

ST 21:0;O2;Tau

ST 21:0;O2;Tau

C23H41NO5S (443.2705296000001)


   

(1r,2s,4s,7s,8r,9s,12s,13s)-16-amino-7-(3,4-dimethylpent-4-en-1-yl)-7-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

(1r,2s,4s,7s,8r,9s,12s,13s)-16-amino-7-(3,4-dimethylpent-4-en-1-yl)-7-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

C28H45NO3 (443.339926)


   

2-methyl-6-(11-oxododecyl)piperidin-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

2-methyl-6-(11-oxododecyl)piperidin-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C27H41NO4 (443.30354260000007)


   

2-(14-hydroxy-14,15-dimethylhexadecyl)-3-methoxy-1h-quinolin-4-one

2-(14-hydroxy-14,15-dimethylhexadecyl)-3-methoxy-1h-quinolin-4-one

C28H45NO3 (443.339926)


   

(2e,4e,6e,8r,10r)-1-[5-(1,4-dihydroxycyclohexyl)-2,4-dihydroxypyridin-3-yl]-6,8,10-trimethyldodeca-2,4,6-trien-1-one

(2e,4e,6e,8r,10r)-1-[5-(1,4-dihydroxycyclohexyl)-2,4-dihydroxypyridin-3-yl]-6,8,10-trimethyldodeca-2,4,6-trien-1-one

C26H37NO5 (443.26715920000004)


   

(1r,2s,4s,7s,8r,9s,12s,13s,16s,18s)-16-amino-7-[(1e,3r)-3,4-dimethylpent-1-en-1-yl]-7-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

(1r,2s,4s,7s,8r,9s,12s,13s,16s,18s)-16-amino-7-[(1e,3r)-3,4-dimethylpent-1-en-1-yl]-7-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

C28H45NO3 (443.339926)


   

2,3-dimethoxy-6-(10-methoxy-3,7,9,11-tetramethyltetradeca-2,5,7,11-tetraen-1-yl)-5-methylpyridin-4-ol

2,3-dimethoxy-6-(10-methoxy-3,7,9,11-tetramethyltetradeca-2,5,7,11-tetraen-1-yl)-5-methylpyridin-4-ol

C27H41NO4 (443.30354260000007)


   

(3s,4as,6ar,6bs,9r,11as,11br)-3-hydroxy-9-[(1r)-1-[(2r,3r,5r)-3-hydroxy-1,5-dimethylpiperidin-2-yl]ethyl]-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

(3s,4as,6ar,6bs,9r,11as,11br)-3-hydroxy-9-[(1r)-1-[(2r,3r,5r)-3-hydroxy-1,5-dimethylpiperidin-2-yl]ethyl]-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO3 (443.339926)


   

(3s,3as,6s,7s,7as)-3-benzyl-7-[(1e,4s,5s,6s)-5,6-dihydroxy-4-methylhept-1-en-1-yl]-6-methoxy-4,5-dimethyl-3,3a,6,7-tetrahydroisoindole-1,7a-diol

(3s,3as,6s,7s,7as)-3-benzyl-7-[(1e,4s,5s,6s)-5,6-dihydroxy-4-methylhept-1-en-1-yl]-6-methoxy-4,5-dimethyl-3,3a,6,7-tetrahydroisoindole-1,7a-diol

C26H37NO5 (443.26715920000004)


   

2-[(14r)-14-hydroxy-14,15-dimethylhexadecyl]-3-methoxy-1h-quinolin-4-one

2-[(14r)-14-hydroxy-14,15-dimethylhexadecyl]-3-methoxy-1h-quinolin-4-one

C28H45NO3 (443.339926)


   

(3s,4as,6ar,6bs,9s,11as,11br)-3-hydroxy-9-[(1r)-1-[(2r,3r,5r)-3-hydroxy-1,5-dimethylpiperidin-2-yl]ethyl]-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

(3s,4as,6ar,6bs,9s,11as,11br)-3-hydroxy-9-[(1r)-1-[(2r,3r,5r)-3-hydroxy-1,5-dimethylpiperidin-2-yl]ethyl]-10,11b-dimethyl-1h,2h,3h,4h,4ah,6h,6ah,6bh,7h,8h,9h,11h,11ah-cyclohexa[a]fluoren-5-one

C28H45NO3 (443.339926)


   

2,3-dimethoxy-6-(10-methoxy-3,5,7,9,11-pentamethyltrideca-2,5,7,11-tetraen-1-yl)-5-methylpyridin-4-ol

2,3-dimethoxy-6-(10-methoxy-3,5,7,9,11-pentamethyltrideca-2,5,7,11-tetraen-1-yl)-5-methylpyridin-4-ol

C27H41NO4 (443.30354260000007)


   

(4s,7s,8r,9s,13s,16s)-16-amino-7-[(1e)-3,4-dimethylpent-1-en-1-yl]-7-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

(4s,7s,8r,9s,13s,16s)-16-amino-7-[(1e)-3,4-dimethylpent-1-en-1-yl]-7-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

C28H45NO3 (443.339926)


   

2,3-dimethoxy-6-[(2e,5e,7e,9r,10r,11e)-10-methoxy-3,7,9,11-tetramethyltetradeca-2,5,7,11-tetraen-1-yl]-5-methylpyridin-4-ol

2,3-dimethoxy-6-[(2e,5e,7e,9r,10r,11e)-10-methoxy-3,7,9,11-tetramethyltetradeca-2,5,7,11-tetraen-1-yl]-5-methylpyridin-4-ol

C27H41NO4 (443.30354260000007)


   

(3s,6e,8r,9s,10z,12s,13r,14r,15s)-3-benzyl-9,13-dihydroxy-4,8,10,12,14,15-hexamethyl-1-oxa-4-azacyclopentadeca-6,10-diene-2,5-dione

(3s,6e,8r,9s,10z,12s,13r,14r,15s)-3-benzyl-9,13-dihydroxy-4,8,10,12,14,15-hexamethyl-1-oxa-4-azacyclopentadeca-6,10-diene-2,5-dione

C26H37NO5 (443.26715920000004)


   

(1's,2s,3s,3'r,5r,7'r,13's,15'r)-15'-hydroxy-12'-(2-hydroxyethyl)-3,3',15'-trimethyl-5-(2-methylprop-1-en-1-yl)-12'-azaspiro[oxolane-2,6'-tetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecan]-10'(16')-en-11'-one

(1's,2s,3s,3'r,5r,7'r,13's,15'r)-15'-hydroxy-12'-(2-hydroxyethyl)-3,3',15'-trimethyl-5-(2-methylprop-1-en-1-yl)-12'-azaspiro[oxolane-2,6'-tetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecan]-10'(16')-en-11'-one

C27H41NO4 (443.30354260000007)


   

3-benzyl-9,13-dihydroxy-4,8,10,12,14,15-hexamethyl-1-oxa-4-azacyclopentadeca-6,10-diene-2,5-dione

3-benzyl-9,13-dihydroxy-4,8,10,12,14,15-hexamethyl-1-oxa-4-azacyclopentadeca-6,10-diene-2,5-dione

C26H37NO5 (443.26715920000004)


   

(2e,4e,6e,8r,10r)-1-{2,4-dihydroxy-5-[(1s,4s)-1,4-dihydroxycyclohexyl]pyridin-3-yl}-6,8,10-trimethyldodeca-2,4,6-trien-1-one

(2e,4e,6e,8r,10r)-1-{2,4-dihydroxy-5-[(1s,4s)-1,4-dihydroxycyclohexyl]pyridin-3-yl}-6,8,10-trimethyldodeca-2,4,6-trien-1-one

C26H37NO5 (443.26715920000004)


   

16-amino-7-(3,4-dimethylpent-1-en-1-yl)-7-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

16-amino-7-(3,4-dimethylpent-1-en-1-yl)-7-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-one

C28H45NO3 (443.339926)


   

2-[(5r,8r,10r,11r,12s,14s,16r,17r)-12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate

2-[(5r,8r,10r,11r,12s,14s,16r,17r)-12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate

C26H37NO5 (443.26715920000004)


   

3,11-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

3,11-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

C27H41NO4 (443.30354260000007)


   

2-[(1r,5r,8r,10r,11r,12s,14s,16r,17r)-12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate

2-[(1r,5r,8r,10r,11r,12s,14s,16r,17r)-12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate

C26H37NO5 (443.26715920000004)


   

(1r,2r,4s,5s,7r,8r,13r,16r,17r)-4-(acetyloxy)-11-ethyl-16-hydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-7-yl acetate

(1r,2r,4s,5s,7r,8r,13r,16r,17r)-4-(acetyloxy)-11-ethyl-16-hydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-7-yl acetate

C26H37NO5 (443.26715920000004)


   

2-[12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate

2-[12-(acetyloxy)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-7-yl]ethyl acetate

C26H37NO5 (443.26715920000004)


   

(3s,3'r,3'as,4as,6's,6as,6bs,7'ar,9r,11r,11as,11br)-3,11-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

(3s,3'r,3'as,4as,6's,6as,6bs,7'ar,9r,11r,11as,11br)-3,11-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5',6,6',6a,6b,7,7',7'a,8,11,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-5-one

C27H41NO4 (443.30354260000007)


   

(1r,2s,4s,7r,8s,9s,10s,11r,12r)-8-(acetyloxy)-12-ethoxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-9-yl acetate

(1r,2s,4s,7r,8s,9s,10s,11r,12r)-8-(acetyloxy)-12-ethoxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-9-yl acetate

C26H37NO5 (443.26715920000004)


   

2-methyl-6-(11-oxododecyl)piperidin-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

2-methyl-6-(11-oxododecyl)piperidin-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C27H41NO4 (443.30354260000007)


   

1,3-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5,5',6,6',6a,6b,7,7',7'a,8,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-11-one

1,3-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5,5',6,6',6a,6b,7,7',7'a,8,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-11-one

C27H41NO4 (443.30354260000007)


   

2,3-dimethoxy-6-[(2e,5e,7e,9s,10s,11e)-10-methoxy-3,7,9,11-tetramethyltetradeca-2,5,7,11-tetraen-1-yl]-5-methylpyridin-4-ol

2,3-dimethoxy-6-[(2e,5e,7e,9s,10s,11e)-10-methoxy-3,7,9,11-tetramethyltetradeca-2,5,7,11-tetraen-1-yl]-5-methylpyridin-4-ol

C27H41NO4 (443.30354260000007)


   

(1r,2s,4s,7r,8s,9s,10s,11r,12s)-8-(acetyloxy)-12-ethoxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-9-yl acetate

(1r,2s,4s,7r,8s,9s,10s,11r,12s)-8-(acetyloxy)-12-ethoxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-en-9-yl acetate

C26H37NO5 (443.26715920000004)


   

(2e,4e,6e,8r,10r)-1-{2,4-dihydroxy-5-[(1r,4r)-1,4-dihydroxycyclohexyl]pyridin-3-yl}-6,8,10-trimethyldodeca-2,4,6-trien-1-one

(2e,4e,6e,8r,10r)-1-{2,4-dihydroxy-5-[(1r,4r)-1,4-dihydroxycyclohexyl]pyridin-3-yl}-6,8,10-trimethyldodeca-2,4,6-trien-1-one

C26H37NO5 (443.26715920000004)


   

(1s,3r,3'r,3'as,4as,6's,6as,6bs,7'ar,9r,11as,11bs)-1,3-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5,5',6,6',6a,6b,7,7',7'a,8,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-11-one

(1s,3r,3'r,3'as,4as,6's,6as,6bs,7'ar,9r,11as,11bs)-1,3-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5,5',6,6',6a,6b,7,7',7'a,8,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-11-one

C27H41NO4 (443.30354260000007)


   

2,3-dimethoxy-6-[(2e,5e,7e,9s,10s,11e)-10-methoxy-3,5,7,9,11-pentamethyltrideca-2,5,7,11-tetraen-1-yl]-5-methylpyridin-4-ol

2,3-dimethoxy-6-[(2e,5e,7e,9s,10s,11e)-10-methoxy-3,5,7,9,11-pentamethyltrideca-2,5,7,11-tetraen-1-yl]-5-methylpyridin-4-ol

C27H41NO4 (443.30354260000007)


   

2-[(2e,5e,7e,11z)-10-hydroxy-3,7,9,11,13-pentamethyltetradeca-2,5,7,11-tetraen-1-yl]-5,6-dimethoxy-3-methylpyridin-4-ol

2-[(2e,5e,7e,11z)-10-hydroxy-3,7,9,11,13-pentamethyltetradeca-2,5,7,11-tetraen-1-yl]-5,6-dimethoxy-3-methylpyridin-4-ol

C27H41NO4 (443.30354260000007)


   

(1r,3r,3'r,3'as,4ar,6's,6as,6bs,7'ar,9r,11as,11bs)-1,3-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5,5',6,6',6a,6b,7,7',7'a,8,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-11-one

(1r,3r,3'r,3'as,4ar,6's,6as,6bs,7'ar,9r,11as,11bs)-1,3-dihydroxy-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',4a,5,5',6,6',6a,6b,7,7',7'a,8,11a-octadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-11-one

C27H41NO4 (443.30354260000007)


   

1-[5-(1,4-dihydroxycyclohexyl)-2,4-dihydroxypyridin-3-yl]-6,8,10-trimethyldodeca-2,4,6-trien-1-one

1-[5-(1,4-dihydroxycyclohexyl)-2,4-dihydroxypyridin-3-yl]-6,8,10-trimethyldodeca-2,4,6-trien-1-one

C26H37NO5 (443.26715920000004)